http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2021163159-A1

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_37652508ed72cf8cfb4a14230f4a4dd7
classificationCPCAdditional http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61F2250-0069
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61F2250-0068
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61F9-0017
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61F9-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61M39-04
filingDate 2021-02-10-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_b0f81d3e920339e27d4dd0cdab35acde
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_fb2cd8e93fb16048b5b3d96adcac01de
publicationDate 2021-08-19-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber WO-2021163159-A1
titleOfInvention Implantable drug delivery device with a self-sealing reservoir for treating ocular diseases
abstract Implantable devices and systems and methods are provided for controlled delivery of a therapeutic agent to the eye, which employ a flexible reservoir for holding a supply of the therapeutic agent, and a flexible tube that extends from the reservoir. The tube has an inlet end in fluid communication with the interior space of the reservoir, an outlet end spaced from the reservoir, and a lumen that extends from the inlet end to the outlet end. The lumen of the tube is configured to deliver therapeutic agent from the reservoir through the tube.
priorityDate 2020-02-14-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2014276329-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2011196195-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2006036231-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2013218104-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2005055075-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2009311133-A1
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID13360
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID4763
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226400370
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226406705
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID16850
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID7765
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5743
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226394110
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226395888
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID2244
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226405430
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226406750

Total number of triples: 33.